Gpr84 activation induces anti-mycobacterial defense in macrophages via MAPK signaling
Immunobiology · 2026-11 · 231 (6) · 153253
DOI: 10.1016/j.imbio.2026.153253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunobiology, 2026-11. Verfasst von Seoyeon Jo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, 35015, Republic of Korea; Department of Microbiology, Coll…. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Tuberculosis (TB), a disease caused by Mycobacterium tuberculosis (Mtb), remains a significant global health threat. The complete pathogenesis of Mtb infection within the host remains insufficiently elucidated, highlighting the urgent need for research focused on host-directed therapeutic strategies targeting infected immune cells. G protein-coupled receptor 84 (Gpr84), an inflammatory receptor expressed on the surface of immune cells, is known to induce inflammatory responses upon activation. We hypothesized that Gpr84 plays a pivotal role in regulating the macrophage response to Mtb infection. In this study, we investigated the role of Gpr84 in controlling intracellular Mtb survival within macrophages. Genetic knockdown of Gpr84 using small interfering RNA (siRNA) significantly increased the Mtb burden. Conversely, treating Mtb-infected macrophages with the Gpr84 agonist 6-n-octylaminouracil (6-OAU) led to a pronounced, dose-dependent reduction in bacterial load. Mechanistically, Gpr84 activation enhanced the production of pro-inflammatory cytokines and robustly increased the activation of the MAPK pathway (Erk and Jnk), suggesting a direct mechanism for bacterial clearance. Our findings define Gpr84 as a critical component of host anti-mycobacterial defense, inhibiting Mtb growth in macrophages via the MAPK signaling cascade. This study strongly identifies Gpr84 as a promising host-directed therapeutic target for combating drug-resistant TB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, 35015, Republic of Korea; Department of Microbiology, College of Medicine, Chungnam National University, Daejeon, 35015, Republi…
Förderung
- National Research Foundation of Korea
Zitieren
APA
Jo, S., Lee, J., Kim, J., Choi, J. A., Nguyen, T. D., Choi, S., & Song, C. H. (2026). Gpr84 activation induces anti-mycobacterial defense in macrophages via MAPK signaling. Immunobiology, 231(6), 153253. https://doi.org/10.1016/j.imbio.2026.153253
Vancouver
Jo S, Lee J, Kim J, Choi JA, Nguyen TD, Choi S, et al. Gpr84 activation induces anti-mycobacterial defense in macrophages via MAPK signaling. Immunobiology. 2026;231(6):153253. doi:10.1016/j.imbio.2026.153253
BibTeX
@article{Jo2026,
author = {Jo, Seoyeon and Lee, Junghwan and Kim, Jaewhan and Choi, Ji-Ae and Nguyen, Tam Doan and Choi, Subin and Song, Chang-Hwa},
title = {Gpr84 activation induces anti-mycobacterial defense in macrophages via MAPK signaling},
journal = {Immunobiology},
year = {2026},
volume = {231},
number = {6},
pages = {153253},
doi = {10.1016/j.imbio.2026.153253}
}
EUVIMED